GL1X · GenesisL1 explorer

Research workbench

Crystal structure of trail-DR5 complex

Analyse Crystal structure of trail-DR5 complex in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1D4V
Type
protein
Length
280 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
TNF-related apoptosis inducing ligand; Death receptor 5
UniProt
P50591
Pockets
3 · best druggability 0.45

Structure

x-ray diffraction · 2 distinct chains · 1% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BTNF-related apoptosis inducing ligandprotein1632% helix, 48% strandP50591
ADeath receptor 5protein1170% helix, 29% strand—

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11560.450.7630empty
2650.300.7517empty
3830.290.7218empty

Interfaces

1 interface between chains.

  • B–A · 772 Ų buried · 10 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 1D4V · Crystal structure of trail-DR5 complex · the same entry in another collection · chain B against B, TM-score 1.00
  • P50591 · AlphaFold monomer V2.0 prediction for tumor necrosis factor ligand superfamily member 10… · a predicted model of the same protein · chain B against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.